Re-Thinking Clinical Trials in Oncology
Assessing the landscape of novel trial design for cancer therapies to improve data collection, enhance patient access, and drive clinical outcomes for breakthrough therapies

October 28, 2020 | Live Virtual Forum (EST)

View Program

Vendor Registration

Free Registration

Meet the Speakers

View the event program for additional information on speakers, sessions, networking activities, and more!

Speakers

Michel Azoulay MD
Senior Medical Director Oncology
Kyowa Kirin

Amy Abernethy MD, PhD
Principal Deputy Commissioner, Acting CIO
US Food & Drug Administration (FDA)

Dr. Kevin Knopf MD
Division Chief Hematology/Oncology
Highland Hospital/ Alameda Health System

David S. Hong MD
Associate Vice President of Clinical Research
M.D. Anderson Cancer Center

Laurie Smaldone MD
CMO/CSO
NDA Group

Marcel Rozencweig
CMO
NeoTX Therapeutics

Caroline Germa
Vice President, Head Clinical Development, Early Portfolio, Oncology R&D
AstraZeneca

Marvella E. Ford, PhD
Associate Director, Population Sciences and Cancer Disparities; SmartState Endow
Hollings Cancer Center; University of South Carolina and South Carolina State University

Melissa Gonzales
Inclusion Principal, External Partnering
Genentech

Gracie Lieberman
Senior Director Regulatory Policy
Genentech

Lola Fashoyin-Aje
Deputy Division Director (acting) & Assoc. Dir, Science & Policy to Address Disp
Food and Drug Administration

David Thompson
Senior Vice President, Real World Research
Syneos Health

Ann Collins
Vice President, Clinical Development
Syneos Health

Kieron Lewis
Business Development Director
Clinigen

Craig Lipset
Assistant Professor of Health Informatics
Rutgers University

Kenneth G. Faulkner PhD
Vice President of eCOA Scientific Services
ERT

Sandra Vingerhoedt
Clinical Project Manager
Bayer AG, Belgium

In Partnership With :

QUESTIONS?
Contact us: 1-800-882-8684
Email: enquiry@iqpc.com

Re-Thinking Clinical Trials in Oncology Assessing the landscape of novel trial design for cancer therapies to improve data collection, enhance patient access, and drive clinical outcomes for breakthrough therapies

Meet the Speakers

Speakers

In Partnership With :

Re-Thinking Clinical Trials in Oncology
Assessing the landscape of novel trial design for cancer therapies to improve data collection, enhance patient access, and drive clinical outcomes for breakthrough therapies